Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesNeogen Corporation

Neogen Corporation

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
11.45 USD -0.15 ( 1.29%)
Last update at 2026-11-12T15:47:00Z
VOLUME
245396
Market Cap
2671.80M

Momentum Score

…

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
11.26
Low
11.56
High
52 Week Price Range
5.09
Low
12.85
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
11.60
Dividend Yield
-
Revenue TTM
870.40M
Revenue Per Share
4.00
Gross Profit TTM
408.50M
Debt / Equity
0.38
ROE
-0.38%
Net Debt
608.20M
ROCE
1.52%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Type yearly yearly yearly yearly yearly
Date 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Income before tax -9.00M -1133.11M -14.30M -22.04M 60.21M
Net income -7.90M -1092.04M -9.42M -22.87M 48.31M
Selling general administrative 245.10M 218.17M 199.89M 201.18M 82.74M
Selling and marketing expenses 166.60M 183.80M 182.87M 141.22M 84.60M
Gross profit 408.50M 421.38M 462.63M 405.95M 243.01M
Reconciled depreciation 121.90M 125.67M 121.23M 88.38M 23.69M
Ebit 48.60M -1063.43M 61.37M -50.86M 34.92M
Ebitda 170.50M -937.75M 182.60M 37.52M 58.62M
Depreciation and amortization 121.90M 125.67M 121.23M 88.38M 23.69M
Non operating income net other - - - -6.76M 0.32M
Operating income -21.60M 9.42M 77.43M 37.52M 34.92M
Other operating expenses 892.00M 885.24M 846.80M 784.93M 468.54M
Interest expense 57.60M 71.62M 73.39M 55.96M 1.27M
Tax provision -1.10M -41.07M -4.88M 0.83M 11.90M
Interest income - 3.11M 6.36M 3.17M 1.27M
Net interest income -57.60M -68.51M -67.03M -52.80M 1.27M
Income tax expense -1.10M -41.07M -4.88M 0.83M 11.90M
Total revenue 870.40M 894.66M 924.22M 822.45M 527.16M
Total operating expenses 430.10M 411.96M 385.21M 368.44M 184.40M
Cost of revenue 461.90M 473.29M 461.59M 416.49M 284.15M
Total other income expense net 12.60M -1142.53M -91.73M -59.56M 25.28M
Net income from continuing ops -7.90M -1092.04M -9.42M -22.87M 48.31M
Net income applicable to common shares - - - -22.87M 48.31M
Breakdown 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Type yearly yearly yearly yearly yearly
Date 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total assets 3346.00M 3443.84M 4548.83M 4554.43M 992.93M
Intangible assets 1318.00M 1410.48M 1511.65M 1605.10M 107.50M
Other current assets 128.00M 103.69M 56.02M 53.30M 23.76M
Total liab 1253.10M 1372.58M 1404.69M 1420.21M 105.56M
Total stockholder equity 2092.90M 2071.25M 3144.14M 3134.22M 887.37M
Deferred long term liab - - - 1.51M -
Other current liab 68.30M 55.88M 46.19M 64.19M 37.77M
Common stock 34.80M 34.73M 34.66M 34.60M 17.25M
Capital stock 34.80M 34.73M 34.66M 34.60M 17.25M
Retained earnings -544.30M -536.42M 555.62M 565.04M 587.91M
Other liab - - - 375.72M 27.71M
Good will 1047.20M 1064.90M 2135.63M 3769.75M 255.55M
Other assets - - 0.00M 15.22M 4799.03M
Cash 185.50M 129.00M 170.61M 163.24M 381.05M
Total current liabilities 158.20M 174.01M 154.32M 145.47M 77.84M
Current deferred revenue 3.60M 5.56M 4.63M 4.62M 5.46M
Net debt 608.20M 783.61M 735.63M 736.76M 605.64M
Short term debt - 27.37M 9.99M - -
Short long term debt - 19.30M 2.45M - -
Short long term debt total 793.70M 912.61M 906.24M 900.00M 986.69M
Other stockholder equity 2616.00M 2601.85M 2583.89M 2567.83M 309.98M
Property plant equipment - - - 198.75M 110.58M
Total current assets 604.60M 576.94M 589.23M 585.93M 626.80M
Net tangible assets - - - 3134.22M 887.37M
Short term investments - 0.00M 0.33M 82.33M 336.58M
Net receivables 146.80M 153.38M 173.00M 153.25M 99.67M
Long term debt 793.70M 874.81M 888.39M 885.44M -
Inventory 144.30M 190.86M 189.27M 133.81M 122.31M
Accounts payable 79.10M 79.61M 83.06M 76.67M 34.61M
Accumulated other comprehensive income -13.60M -28.90M -30.02M -33.25M -27.77M
Common stock total equity - - - 34.60M 17.25M
Retained earnings total equity - - - 565.04M 587.91M
Non currrent assets other -120.80M 35.23M 20.20M 3769.75M 2.16M
Non current assets total 2741.40M 2866.90M 3959.60M 3968.50M 366.13M
Capital lease obligations 0.00M - 2.45M - -
Breakdown 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Type yearly yearly yearly yearly yearly
Date 2026-05-31 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Investments 0.00M -99.19M -29.31M 254.25M -34.05M
Change to liabilities - - - 22.69M 26.50M
Total cashflows from investing activities 70.50M -99.19M -29.31M 201.04M -97.23M
Net borrowings -100.10M -0.32M -0.42M -119.28M -100.00M
Total cash from financing activities -99.40M -1.60M 1.92M -118.08M 6.81M
Change to operating activities - - - 2.50M 12.23M
Net income -7.90M -1092.04M -9.42M -22.87M 48.31M
Change in cash 56.50M -41.61M 7.37M 118.77M -31.13M
Begin period cash flow 129.00M 170.61M 163.24M 44.47M 75.60M
End period cash flow 185.50M 129.00M 170.61M 163.24M 44.47M
Total cash from operating activities 83.20M 58.24M 35.26M 41.03M 68.04M
Depreciation 116.30M 125.67M 121.23M 88.38M 23.69M
Other cashflows from investing activities 0.10M -99.52M 0.11M 12.55M -38.74M
Change to inventory 38.20M -16.12M -55.95M 9.96M -21.07M
Change to account receivables 6.80M 11.64M -20.10M -53.88M -7.80M
Sale purchase of stock - - - 1.20M 7.93M
Other cashflows from financing activities -1.00M -3.52M -0.12M -19.28M -1.12M
Change to netincome - - - -6.43M 2.46M
Capital expenditures 51.30M 104.59M 111.42M 65.76M 24.43M
Change receivables - - - -53.88M -7.80M
Cash flows other operating - - - 0.46M -4.05M
Cash and cash equivalents changes - - - 123.99M -22.38M
Change in working capital 58.80M -5.93M -72.68M -22.79M -6.42M
Stock based compensation 13.40M 17.29M 13.77M 10.18M 7.15M
Other non cash items -73.10M 1071.04M 9.80M 7.36M 73.20M
Free cash flow 31.90M -46.35M -76.16M -24.73M 43.61M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NEOG
Neogen Corporation		 -0.15
1.29%		 11.45 - 16.00 3.07 1.25 3.70 18.87
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

620 Lesher Place, Lansing, MI, United States, 48912-1595

517 372 9200

https://www.neogen.com

2636

Name Title Year Born
Mr. John Edward Adent Pres, CEO & Director 1968
Mr. Steven J. Quinlan VP & CFO 1962
Mr. Douglas E. Jones COO & VP 1970
Sarah Demey Admin. Mang. NA
Ms. Amy M. Rocklin Ph.D. VP, Gen. Counsel & Corp. Sec. 1972
Ms. Julie A. Mann VP & Chief HR Officer 1965
Mr. John Edward Adent President, CEO & Director 1968
Mr. David H. Naemura Chief Financial Officer 1970
Dr. Robert S. Donofrio Ph.D. VP & Chief Scientific Officer 1975
Sarah Demey Administrative Manager NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…